Companies /Healthcare
Vertex Pharmaceuticals Inc
NASDAQ: VRTX Biotechnology
$505.64
▲ $3.33 (+0.66%) today
Markets closed · 7:04pm ET

Vertex Pharmaceuticals (VRTX) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
50%
EPS beat rate
+1.16%
Avg. EPS surprise
Consecutive EPS misses
VRTX vs Market · 30-day return after each reportVRTXS&P 500
−7%0%+7%+14%+0.1%+7.2%Q1 25+5.6%+3.1%Q2 25+8.0%+1.6%Q3 25−8.1%−3.0%Q4 25+5.3%+1.9%Q1 26+16.6%+0.2%Q2 26
−7%0%+7%+14%Q1 25Q3 25Q1 26
VRTX EPS Trend · estimate vs actualEstimateActual
$0$2$4$4.29$4.06Q1 25$4.25$4.52Q2 25$4.58$4.80Q3 25$5.15$5.03Q4 25$4.31$4.47Q1 26$4.75$4.73Q2 26
$0$2$4Q1 25Q3 25Q1 26
VRTX Revenue Trend · estimate vs actualEstimateActual
$0$1.0B$2.0B$3.0B$2.9B$2.8BQ1 25$2.9B$3.0BQ2 25$3.1B$3.1BQ3 25$3.2B$3.2BQ4 25$3.0B$3.0BQ1 26$3.2B$3.3BQ2 26
$0$1.0B$2.0B$3.0BQ1 25Q3 25Q1 26

How Often Does Vertex Pharmaceuticals Beat Earnings Estimates?

Vertex Pharmaceuticals beat EPS estimates in 3 of its last 6 reported quarters.

VRTX quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $4.73 est. $4.75 −0.32% $3.3B est. $3.2B +3.43%
Q1 2026 $4.47 est. $4.31 +3.81% $3.0B est. $3.0B −0.36%
Q4 2025 $5.03 est. $5.15 −2.30% $3.2B est. $3.2B +0.48%
Q3 2025 $4.80 est. $4.58 +4.87% $3.1B est. $3.1B +0.56%
Q2 2025 $4.52 est. $4.25 +6.33% $3.0B est. $2.9B +2.00%
Q1 2025 $4.06 est. $4.29 −5.44% $2.8B est. $2.9B −3.17%

Figures from SEC filings and company reports. Not investment advice.